Data Science in the News

Did you know we have a monthly newsletter? View past volumes and subscribe.

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

June 30, 2022 - 
Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

June 7, 2022 - 
The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

Kevin McLoughlin applies computational biology to complex problems

May 17, 2022 - 
Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Machine learning model finds COVID-19 risks for cancer patients

March 10, 2022 - 
A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

Feb. 15, 2022 - 
An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

Building confidence in materials modeling using statistics

Oct. 31, 2021 - 
LLNL statisticians, computational modelers, and materials scientists have been developing a statistical framework for researchers to better assess the relationship between model uncertainties and experimental data. The Livermore-developed statistical framework is intended to assess sources of uncertainty in strength model input, recommend new experiments to reduce those sources of uncertainty...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Oct. 21, 2021 - 
LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Summer scholar develops data-driven approaches to key NIF diagnostics

Oct. 20, 2021 - 
Su-Ann Chong's summer project, “A Data-Driven Approach Towards NIF Neutron Time-of-Flight Diagnostics Using Machine Learning and Bayesian Inference,” is aimed at presenting a different take on nToF diagnostics. Neutron time-of-flight diagnostics are an essential tool to diagnose the implosion dynamics of inertial confinement fusion experiments at NIF, the world’s largest and most energetic...

Tackling the COVID-19 pandemic

Oct. 11, 2021 - 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Brian Gallagher combines science with service

June 20, 2021 - 
Brian Gallagher works on applications of machine learning for a variety of science and national security questions. He’s also a group leader, student mentor, and the new director of LLNL’s Data Science Challenge. The Lab has enabled Gallagher to combine scientific pursuits with leadership positions and people-focused responsibilities. “For a long time, my primary motivation was learning new...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021 - 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Advanced Data Analytics for Proliferation Detection shares technical advances during two-day meeting

May 7, 2021 - 
The Advanced Data Analytics for Proliferation Detection (ADAPD) program held a two-day virtual technical exchange meeting recently. The goal of the meeting was to highlight the science-based and data-driven analysis work conducted by ADAPD to advance the state-of-the-art to accelerate artificial intelligence (AI) innovation and develop AI-enabled systems to enhance the United States’...

COVID-19 HPC Consortium reflects on past year

April 1, 2021 - 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Ana Kupresanin featured in FOE alumni spotlight

March 10, 2021 - 
LLNL's Ana Kupresanin, deputy director of the Center for Applied Scientific Computing and member of the Data Science Institute council, was recently featured in a Frontiers of Engineering (FOE) alumni spotlight. Kupresanin develops statistical and machine learning models that incorporate real-world variability and probabilistic behavior to quantify uncertainties in engineering and physics...

LLNL physicist wins Young Former Student award

Dec. 16, 2020 - 
Texas A&M University’s Department of Nuclear Engineering on December 10 announced it has honored LLNL physicist Kelli Humbird with its 2020-21 Young Former Student award for her work at LLNL in combining machine learning with inertial confinement fusion (ICF) research. Humbird graduated from Texas A&M with a PhD in nuclear engineering in 2019. Since joining the Laboratory as an intern in 2016...

Model for COVID-19 drug discovery a Gordon Bell finalist

Nov. 17, 2020 - 
A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

What put LLNL at the center of U.S. supercomputing in 2020?

Nov. 12, 2020 - 
The HPC world is waiting for the next series of transitions to far larger machines with exascale capabilities. By this time next year, the bi-annual ranking of the Top500 most powerful systems will be refreshed at the top as Frontier, El Capitan, Aurora, and other DOE systems come online. While LLNL was already planning around AI acceleration for its cognitive simulation aims and had a number...

From intern to mentor, Nisha Mulakken builds a career in bioinformatics

Nov. 3, 2020 - 
The COVID-19 pandemic has sparked a wave of new research and development at the Lab, and Nisha Mulakken is very busy. The biostatistician has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated...

AI gets a boost via LLNL, SambaNova collaboration

Oct. 20, 2020 - 
LLNL has installed a state-of-the-art artificial intelligence (AI) accelerator from SambaNova Systems, the National Nuclear Security Administration (NNSA) announced today, allowing researchers to more effectively combine AI and machine learning (ML) with complex scientific workloads. LLNL has begun integrating the new AI hardware, SambaNova Systems DataScale™, into the NNSA’s Corona...

LLNL, ANL and GSK provide early glimpse into Cerebras AI system performance

Oct. 13, 2020 - 
AI chip and systems startup Cerebras was one of many AI companies showcased at the AI Hardware Summit which concluded last week. Cerebras invited collaborators from LLNL, Argonne National Laboratory, and GlaxoSmithKline to talk about their early work on Cerebras machines and future plans. Livermore Computing's CTO Bronis de Supinski said, “We have this vision for performing cognitive...